 | Pages in this category should be moved to subcategories where applicable. This category may require frequent maintenance to avoid becoming too large. It should directly contain very few, if any, pages and should mainly contain subcategories. |
Contents
Subcategories
This category has the following 6 subcategories, out of 13 total.
(previous page) (next page)I
- Cancer immunotherapy (1 C, 19 P)
O
- Oncothermia (6 P)
R
- Radiation therapy (3 C, 68 P)
S
- Surgical oncology (65 P)
T
- Targeted therapy (7 P)
V
- Cancer vaccines (28 P)
Pages in category "Cancer treatments"
The following 64 pages are in this category, out of 113 total. This list may not reflect recent changes.
(previous page) (next page)I
L
- Lasers in cancer treatment
- Lifileucel
- Linear particle accelerator
- Lisocabtagene maraleucel
- Lomustine
- Lymphatogenous metastasis
M
N
- Nadofaragene firadenovec
- Neoadjuvant therapy
- NeuVax
- NGR-hTNF (antitumor recombinant protein)
- Nigro protocol
- Niraparib/abiraterone acetate
- Nitrogen mustard
- NK-92
O
P
- Panobinostat
- Peptide receptor radionuclide therapy
- Percutaneous hepatic perfusion
- PH-responsive tumor-targeted drug delivery
- PHEC-66
- Photodynamic therapy
- Photostatin
- Plasmonic nanoparticles
- Predictive marker
- Prehabilitation
- Procarbazine
- Prophylactic cranial irradiation
- Management of prostate cancer
R
S
T
- Tabelecleucel
- Tagraxofusp
- Targeted alpha-particle therapy
- Targeted therapy of lung cancer
- Tazemetostat
- Temozolomide
- Thiotepa
- Tislelizumab
- Tivozanib
- Trametinib
- Treatment of lung cancer
- Tucatinib
- Tumor board review
- Tumour heterogeneity